Intervention not reported
Seizure frequency (1‐ to 3‐month blinded evaluation periods) · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review
- no estimate extracted3 studies · 15 participantsModerate
Findings
What do systematic reviews say?
4,695 questions · 4,979 findings · 433 reviews
No studies found 998 · 20%GRADE not reported 1,140 · 22.9%Very low 1,024 · 20.6%Low 1,029 · 20.7%Moderate 636 · 12.8%High 152 · 3.1%
Intervention not reported
Adverse events · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review
- no estimate extracted3 studies · 15 participantsLow
Intervention not reported
Neuropsychological outcome (1‐ to 3‐month periods) · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review
- no estimate extracted2 studies · 6 participantsVery low
Intervention not reported
Quality of life (QOLIE‐89) (1‐ to 3‐month periods) · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review
- no estimate extracted1 study · 3 participantsVery low
Education, self‐monitoring plus education, and decision aids vs usual care
Percentage of time within the therapeutic range · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
- Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 69 participantsVery low
Education, self‐monitoring plus education, and decision aids vs usual care
Anxiety · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
- Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 587 participantsLow
Education, self‐monitoring plus education, and decision aids vs usual care
Depression Measured after 52 weeks HADS depression score, 0‐21 points Low score means fewer symptoms · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
- Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 587 participantsLow
Education, self‐monitoring plus education, and decision aids vs usual care
Decisional conflict · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
- Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 721 participantsLow
Acupuncture vs oral antibiotics plus warm compresses
Resolution of hordeolum at short term · people with acute hordeolum
Acupuncture may leads to higher resolution of hordeolum at short term compared with oral antibiotics plus warm compresses (low certainty).
1 finding from 1 review
- RR 1.45 [1.18, 1.78]1 study · 120 participantsLow
Acupuncture vs oral antibiotics plus warm compresses
Resolution of hordeolum between 8 and 30 days after diagnosis, or that closest to 14 days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Acupuncture vs oral antibiotics plus warm compresses
Participants who required surgical incision and drainage after the treatment period or seven days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Acupuncture vs oral antibiotics plus warm compresses
Participants experiencing the occurrence of a chalazion after the treatment period or seven days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Acupuncture vs oral antibiotics plus warm compresses
Participants experiencing the recurrence of a hordeolum within six months and one year · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Acupuncture vs oral antibiotics plus warm compresses
Participants with a secondary hordeolum during or after the treatment period and seven days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Acupuncture vs oral antibiotics plus warm compresses
Adverse effects · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intravenous fluid supplementation vs oral fluid supplementation
Number of infants with abnormal neurological signs · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
- Fluid supplementation for neonatal unconjugated hyperbilirubinaemia 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 54 participantsGRADE not reported
Intravenous fluid supplementation vs oral fluid supplementation
Bilirubin (µmol/L) · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
- Fluid supplementation for neonatal unconjugated hyperbilirubinaemia 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 54 participantsModerate
Intravenous fluid supplementation vs oral fluid supplementation
Rate of change in bilirubin (μmol/L/hour): during the first 4 hours of admission · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
- Fluid supplementation for neonatal unconjugated hyperbilirubinaemia 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 54 participantsModerate
Dietary supplements (alpha lipoic acid +/- vitamins/lycopene/green tea; hypericum; Catuama; lycopene) vs placebo
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
1 finding from 1 review
- Interventions for treating burning mouth syndrome 2016 · Cochrane All outcomesshort-term (up to 3 months)SoF5 Dietary supplements vs placebo. Symptom relief short-term: insufficient or contradictory evidence regarding benefit of any evaluated dietary supplement; 628 participants (12 RCTs); very low. Subgroups: ALA without…12 studies · 628 participantsVery low
Benzodiazepines (topical clonazepam) vs placebo
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether benzodiazepines (topical clonazepam) changes relief of burning/discomfort (symptom relief; pain intensity) compared with placebo (very low certainty).
2 findings from 1 review
- Interventions for treating burning mouth syndrome 2016 · Cochrane All outcomesshort-term (up to 3 months) · topical clonazepamMD -1.89 [-2.19, -1.59]2 studies · 111 participantsVery low
- Interventions for treating burning mouth syndrome 2016 · Cochrane All outcomeslong-term (>3 to 6 months) · topical clonazepamMD -1.39 [-1.96, -0.83]1 study · 66 participantsVery low